Table 7.
Efficacy of ribavirin monotherapy in immunosuppressed patients.
| References | Enrolled patients | The reason for immunosuppression | Administration period (months) | Patients with sustained viral response |
|---|---|---|---|---|
| Alric et al. (160) | 1 | Hematological pathology | 3 | 1 |
| Chaillon et al. (161) | 1 | Heart transplantation | 3 | 1 |
| 1 | Renal transplantation | 3 | 1 | |
| 1 | Liver transplantation | 3 | 1 | |
| Hajji et al. (164) | 1 | Human immunodeficiency virus infection | 3 | 1 |
| Junge et al. (165) | 1 | Heart transplantation | 6 | 1 |
| Kamar et al. (166) | 8 | Renal transplantation | 3 | 4 |
| Koning et al. (167) | 4 | Heart transplantation | 3-12 | 3 |
| Mallet et al. (168) | 2 | Simultaneous kidney/pancreas transplantation and hematological pathology | 3 | 2 |
| Neukam et al. (169) | 1 | Human immunodeficiency virus infection | 6 | 1 |
| Pischke et al. (155) | 11 | Renal, heart and lung transplantation | 5 | 9 |
| Pischke et al. (152) | 4 | Heart transplantation | 5 | 3 |
| Riezebos-Brilman et al. (170) | 2 | Lung transplantation | 4 | 2 |